机器人根治性顺行模块化胰脾切除与标准逆行胰脾切除的随机对照试验研究方案
本研究为单中心随机对照试验,纳入原发性胰腺癌成人患者,比较机器人根治性顺行模块化胰脾切除(RAMPS)与标准逆行胰脾切除(SRPS)的短期手术和肿瘤学结局。主要终点为R0切除率(切缘距肿瘤≥1 mm),次要终点包括淋巴结获取数、围手术期并发症及指标。
要点
- 机器人RAMPS可能提高R0切除率和淋巴结获取数。
- 主要终点为R0率,切缘距肿瘤≥1 mm定义为R0。
- 需前瞻性RCT评估机器人RAMPS的安全性和疗效。
核心结论
- 机器人RAMPS可能成为机器人胰脾切除的标准术式,但需RCT验证其安全性和临床疗效。
研究设计与样本
- 随机、单中心临床试验,纳入接受RAMPS或SRPS的原发性胰腺癌成人患者。
主要发现
- 既往荟萃分析提示机器人RAMPS在开放和腹腔镜手术下安全有效且肿瘤学优于SRPS,但缺乏机器人RAMPS的临床研究。
关键数值与推荐
- 主要终点为R0切除率,切缘距肿瘤≥1 mm定义为R0。
- 次要终点包括淋巴结获取数、围手术期并发症及围手术期指标(手术时间、出血量、输血量、费用)。
临床怎么用
- 为机器人RAMPS与SRPS的短期手术和肿瘤学结局比较提供前瞻性随机证据。
局限性
- 单中心设计可能限制结果外推性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data from meta-analysis suggest that robotic radical antegrade modular pancreatosplenectomy (RAMPS) is a safe and effective procedure for treating adenocarcinoma in the body or tail of the pancreas, and is oncologically superior to standard retrograde pancreatosplenectomy (SRPS). RAMPS is an operation that actively expands the scope of resection, and achieves a higher R0 resection rate and lymph nodes acquisition through expanded resection. However, previous studies on RAMPS were conducted under open and laparoscopic surgery. Robotic surgery, on the other hand, plays a role in ergonomics and offers several advantages, including less fatigue, tremor filtering, 7° of wrist-like motion, motion scaling, and three-dimensional vision. At present, there is still a world-wide lack of clinical studies to observe the safety and clinical efficacy of robotic RAMPS. Hence, prospective randomized controlled trials (RCTs) comparing robotic RAMPS and SRPS are required. We begin an RCT to compare short-term surgical and oncological outcomes of robotic RAMPS and SRPS in patients undergoing distal pancreatectomy. METHODS: This is a randomized, single-center clinical trial. All participants are adult patients with primary pancreatic cancer, who are undergoing RAMPS or SRPS. The primary endpoints are R0 rate (resection margins are classified by a margin to tumor distance ≥ 1 mm). The secondary endpoints are the number of harvested lymph nodes, perioperative complications and perioperative indicators (duration of surgery, blood loss, blood transfusion volume, costs). DISCUSSION: We are undertaking a prospective RCT to evaluate the surgical and oncological outcomes of robotic RAMPS. This procedure may become a standard approach to robotic pancreatosplenectomy. TRIAL REGISTRATION: Chinese Clinical Trial Registry: ChiCTR1900020833, Registered on 20 January 2019.
引用
- Zhang G, Kang Y, Zhang H, et al. Robotic radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS): study protocol for a randomized controlled trial. Trials. 2020. PMID: 32245518. doi:10.1186/s13063-020-04250-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。